1. Home
  2. MGTX vs NX Comparison

MGTX vs NX Comparison

Compare MGTX & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$9.40

Market Cap

881.7M

Sector

Health Care

ML Signal

HOLD

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

SELL

Current Price

$22.35

Market Cap

901.9M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
MGTX
NX
Founded
2015
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
881.7M
901.9M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
MGTX
NX
Price
$9.40
$22.35
Analyst Decision
Buy
Strong Buy
Analyst Count
8
2
Target Price
★ $27.75
$26.00
AVG Volume (30 Days)
★ 713.0K
375.3K
Earning Date
11-16-2026
12-10-2026
Dividend Yield
N/A
★ 1.42%
EPS Growth
★ 33.02
N/A
EPS
★ 1.30
0.57
Revenue
$81,391,000.00
★ $1,837,641,000.00
Revenue This Year
$314.19
$1.98
Revenue Next Year
N/A
$0.51
P/E Ratio
★ $7.25
$39.61
Revenue Growth
★ 144.57
43.81
52 Week Low
$6.62
$11.04
52 Week High
$15.35
$23.33

Technical Indicators

Market Signals
Indicator
MGTX
NX
Relative Strength Index (RSI) 40.06 58.16
Support Level $8.88 $17.79
Resistance Level $10.11 $21.07
Average True Range (ATR) 0.46 0.95
MACD 0.09 0.24
Stochastic Oscillator 39.83 67.01

Price Performance

Historical Comparison
MGTX
NX

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: